BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32397570)

  • 1. Exploring Kinase Inhibition Properties of 9
    Loidreau Y; Dubouilh-Benard C; Nourrisson MR; Loaëc N; Meijer L; Besson T; Marchand P
    Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32397570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and molecular modelling studies of 8-arylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors.
    Loidreau Y; Deau E; Marchand P; Nourrisson MR; Logé C; Coadou G; Loaëc N; Meijer L; Besson T
    Eur J Med Chem; 2015 Mar; 92():124-34. PubMed ID: 25549552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.
    Loidreau Y; Marchand P; Dubouilh-Benard C; Nourrisson MR; Duflos M; Lozach O; Loaëc N; Meijer L; Besson T
    Eur J Med Chem; 2012 Dec; 58():171-83. PubMed ID: 23124214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr kinases.
    Deau E; Loidreau Y; Marchand P; Nourrisson MR; Loaëc N; Meijer L; Levacher V; Besson T
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6784-8. PubMed ID: 24176400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Microwave Synthesis of New (5
    Bourahla K; Guihéneuf S; Limanton E; Paquin L; Le Guével R; Charlier T; Rahmouni M; Durieu E; Lozach O; Carreaux F; Meijer L; Bazureau JP
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.
    Loidreau Y; Marchand P; Dubouilh-Benard C; Nourrisson MR; Duflos M; Loaëc N; Meijer L; Besson T
    Eur J Med Chem; 2013 Jan; 59():283-95. PubMed ID: 23237976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and kinase inhibitory activity of novel substituted indigoids.
    Beauchard A; Laborie H; Rouillard H; Lozach O; Ferandin Y; Le Guével R; Guguen-Guillouzo C; Meijer L; Besson T; Thiéry V
    Bioorg Med Chem; 2009 Sep; 17(17):6257-63. PubMed ID: 19665384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.
    Bruel A; Bénéteau R; Chabanne M; Lozach O; Le Guevel R; Ravache M; Bénédetti H; Meijer L; Logé C; Robert JM
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5037-40. PubMed ID: 25248682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Biological Evaluation of 7-Chloro-9
    Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure.
    Esvan YJ; Zeinyeh W; Boibessot T; Nauton L; Théry V; Knapp S; Chaikuad A; Loaëc N; Meijer L; Anizon F; Giraud F; Moreau P
    Eur J Med Chem; 2016 Aug; 118():170-7. PubMed ID: 27128181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Cytotoxicity Evaluation of Novel Indole Derivatives as Potential Anti-Cancer Agents.
    Kamel MM; Abdel-Hameid MK; El-Nassan HB; El-Khouly EA
    Med Chem; 2019; 15(8):873-882. PubMed ID: 30961505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Kinase Inhibitors via Metal-Catalyzed C⁻H Arylation of 8-Alkyl-thiazolo[5,4-
    Couly F; Harari M; Dubouilh-Benard C; Bailly L; Petit E; Diharce J; Bonnet P; Meijer L; Fruit C; Besson T
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30158487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary in vitro kinase inhibition evaluation of new diversely substituted pyrido[3,4-g]quinazoline derivatives.
    Zeinyeh W; Esvan YJ; Nauton L; Loaëc N; Meijer L; Théry V; Anizon F; Giraud F; Moreau P
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4327-9. PubMed ID: 27469128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.
    Tazarki H; Zeinyeh W; Esvan YJ; Knapp S; Chatterjee D; Schröder M; Joerger AC; Khiari J; Josselin B; Baratte B; Bach S; Ruchaud S; Anizon F; Giraud F; Moreau P
    Eur J Med Chem; 2019 Mar; 166():304-317. PubMed ID: 30731399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Thiazolo[5,4-f]quinazolin-9(8H)-ones as Multi-Target Directed Ligands of Ser/Thr Kinases.
    Hédou D; Godeau J; Loaëc N; Meijer L; Fruit C; Besson T
    Molecules; 2016 Apr; 21(5):. PubMed ID: 27144552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors.
    Putey A; Fournet G; Lozach O; Perrin L; Meijer L; Joseph B
    Eur J Med Chem; 2014 Aug; 83():617-29. PubMed ID: 24998602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six polycyclic pyrimidoazepine derivatives: syntheses, molecular structures and supramolecular assembly.
    Acosta Quintero LM; Palma A; Cobo J; Glidewell C
    Acta Crystallogr C Struct Chem; 2016 Apr; 72(Pt 4):346-57. PubMed ID: 27045186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and facile synthesis of tricyclic-fused pyrimido[4,5-b]indol-2-amines.
    Gao W; Wang D; Li Y
    Mol Divers; 2017 Nov; 21(4):831-840. PubMed ID: 28631155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel 2,4-bispyridyl thiophene-based compounds as highly potent and selective Dyrk1A inhibitors. Part I: Benzamide and benzylamide derivatives.
    Darwish SS; Abdel-Halim M; Salah M; Abadi AH; Becker W; Engel M
    Eur J Med Chem; 2018 Sep; 157():1031-1050. PubMed ID: 30193214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.